P49841 (GSK3B_HUMAN) Homo sapiens (Human)

Glycogen synthase kinase-3 beta UniProtKBInterProSTRINGInteractive Modelling

420 aa; Sequence (Fasta) ; (Isoform 2); 16 identical sequences

Available Structures

104 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of GSK-3/Axin complex bound to phosphorylated N-terminal auto-inhibitory pS9 pept…
4nm3
 Heteromer
O15169; 		6-383
4×GOL; 2×MG; 1×CL; 1×DTT; 1×ADP;
Assess
Crystal structure of GSK-3/Axin complex bound to phosphorylated Wnt receptor LRP6 c-motif
4nm5
 Heteromer
O15169; O75581; 		24-383
1×ADP; 4×GOL; 2×MG; 1×CL;
Assess
Crystal structure of GSK-3/Axin complex bound to phosphorylated Wnt receptor LRP6 e-motif
4nm7
 Heteromer
O15169; O75581; 		25-383
1×ADP; 3×GOL; 2×MG; 1×CL; 1×DTT;
Assess
Crystal structure of peptide inhibitor-free GSK-3/Axin complex
4nm0
 Heteromer
O15169; 		26-383
5×GOL; 2×MG; 1×ADP; 1×DTT; 1×CL;
Assess
BIO-2895 (BRD0705) bound GSK3beta-axin complex
7sxj
 Heteromer
O15169; 		34-383
1×6VL;
Assess
GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE
1o9u
 Heteromer
O15169; 		35-384
2×ADZ;
Assess
Identification of 2-(4-pyridyl)thienopyridinones as GSK-3beta inhibitors
3zrl
 Heteromer
Q92837; 		36-385
6×SO4; 3×GOL; 2×ZRL;
Assess
Glycogen synthase kinase-3 beta (GSK3) complex with FRATtide peptide
1gng
 Heteromer
Q92837; 		36-385
2×SO4;
Assess
Glycogen Synthase Kinase 3 Beta complexed with Axin Peptide and Leucettine L4
4b7t
 Heteromer
O15169; 		35-384
1×CWT;
Assess
GSK3beta complex with N-(6-(3,4-dihydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)acetamide
5oy4
 Heteromer
Q92837; 		36-385
3×SO4; 1×B4K;
Assess
5-aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors
4afj
 Heteromer
Q92837; 		36-384
3×SO4; 3×GOL; 1×SJJ;
Assess
Identification of 2-(4-pyridyl)thienopyridinones as GSK-3beta inhibitors
3zrk
 Heteromer
Q92837; 		36-384
2×SO4; 2×GOL; 1×ZRK;
Assess
Identification of 2-(4-pyridyl)thienopyridinones as GSK-3beta inhibitors
3zrm
 Heteromer
Q92837; 		36-384
6×SO4; 2×GOL; 2×ZRM;
Assess
Glycogen Synthase Kinase 3 Beta complexed with Axin Peptide and Inhibitor 7d
3zdi
 Heteromer
O15169; 		36-384
1×PO4; 1×UGJ;
Assess
BIO-8546 bound GSK3beta-axin complex
7sxh
 Heteromer
O15169; 		37-383
1×D1E;
Assess
Crystal structure of an activated Akt/protein kinase B (PKB-PIF chimera) ternary complex with AMP-P…
1o6l
 Heteromer
P31751; 		3-12
1×ANP; 2×MN;
Assess
Structure of activated form of PKB kinase domain S474D with GSK3 peptide and AMP-PNP
1o6k
 Heteromer
P31751; 		3-12
1×ANP; 2×MN;
Assess
STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) …
2jdo
 Heteromer
P31751; 		3-12
1×I5S; 1×EDO;
Assess
Structure of 4-Amino-N-(4-chlorobenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin- 4-yl)piperidine-4-carboxamid…
2x39
 Heteromer
P31751; 		3-12
1×X39;
Assess
Crystal Structure of Akt-1 complexed with substrate peptide and inhibitor
3cqw
 Heteromer
P31749; 		3-12
1×MN; 1×CQW;
Assess
STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH 4-(4-chloro-phenyl)-4-(4-(1H-pyrazol-4-yl)-phenyl)-pipe…
2uw9
 Heteromer
P31751; 		3-12
1×GVP;
Assess
Crystal Structure of Akt-1 complexed with substrate peptide and inhibitor
3cqu
 Heteromer
P31749; 		3-12
1×CQU;
Assess
Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors
3e87
 Heteromer
P31751; 		3-12
1×G95;
Assess
Spirochromane Akt Inhibitors
3qkk
 Heteromer
P31749; 		3-12
1×SMH;
Assess
STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH THE INHIBITOR A-443654
2jdr
 Heteromer
P31751; 		3-12
1×L20;
Assess
Crystal structure of AKT1 (aa 144-480) with a bisubstrate
6buu
 Heteromer
P31749; 		3-12
1×SO4; 1×MN;
Assess
Crystal structure of Akt-1-inhibitor complexes
3mv5
 Heteromer
P31749; 		3-12
1×MN; 1×XFE;
Assess
Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors
3e88
 Heteromer
P31751; 		3-12
1×G96;
Assess
Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitors
3ow4
 Heteromer
P31749; 		3-12
1×SMY;
Assess
Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors
3e8d
 Heteromer
P31751; 		3-12
1×G98;
Assess
Structure of 4-(4-tert-Butylbenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4- yl)piperidin-4-amine bound to …
2xh5
 Heteromer
P31751; 		3-12
1×X37;
Assess
Akt1 with AMP-PNP
4ekk
 Heteromer
P31749; 		3-12
1×ANP; 2×MN;
Assess
Binary complex structure of human tau protein kinase I with AMPPNP
1j1b
homo-2-mer23-388
2×ANP;
Assess
Binary complex structure of human tau protein kinase I with ADP
1j1c
homo-2-mer23-388
2×MG; 2×ADP;
Assess
Crystal structure of GSK3b in complex with a pyrimidylpyrrole inhibitor
3i4b
homo-2-mer25-385
2×Z48;
Assess
The Crystal Structure of GSK3b from Biortus.
8xn6
homo-2-mer26-386
2×ANP; 2×MG; 18×EDO; 3×PEG;
Assess
Crystal structure of GSK3 beta (GSK3b) in complex with CD7.
8av1
homo-2-mer27-381
2×SO4; 7×EDO; 2×O9L;
Assess
Crystal structure of GSK3 beta (GSK3b) in complex with FL291.
8auz
homo-2-mer27-381
2×SO4; 2×O9C;
Assess
GSK-3 Beta complexed with Indirubin-3'-monoxime
1q41
homo-2-mer35-386
2×IXM;
Assess
GSK-3 Beta complexed with Alsterpaullone
1q3w
homo-2-mer35-386
2×ATU;
Assess
GSK-3 Beta complexed with AMP-PNP
1pyx
homo-2-mer35-386
4×MG; 2×ANP;
Assess
GSK-3 Beta complexed with Inhibitor I-5
1q4l
homo-2-mer35-386
2×679;
Assess
Glycogen Synthase Kinase 3 beta.
1h8f
homo-2-mer35-386
2×EPE;
Assess
GSK-3 Beta complexed with Staurosporine
1q3d
homo-2-mer35-385
2×STU;
Assess
GSK3b in complex with inhibitor
4acc
homo-2-mer35-385
3×DMS; 2×7YG;
Assess
Extremely Tight Binding of Ruthenium Complex to Glycogen Synthase Kinase 3
2jld
homo-2-mer35-385
2×AG1;
Assess
Crystal structure of GSK3Beta in complex with ARN25068
7oy5
homo-2-mer35-385
2×39I; 6×CL;
Assess
GSK3b in complex with inhibitor
4ach
homo-2-mer35-385
2×KDI;
Assess
GSK3b in complex with inhibitor
4acd
homo-2-mer35-385
2×GR9;
Assess
GSK3b in complex with inhibitor
4acg
homo-2-mer35-385
2×6LQ;
Assess
Structure of a carboxamide compound (3) (2-{2-[(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}-4-OXO-4H-1L…
4ptc
homo-2-mer35-385
2×2WE;
Assess
X-RAY CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH CHIR99021
5hln
homo-2-mer34-384
2×65C; 2×MG; 2×MES;
Assess
Structure of Ruthenium Half-Sandwich Complex Bound to Glycogen Synthase Kinase 3
3m1s
homo-2-mer35-385
2×DW1;
Assess
crystal structure of Glycogen synthase kinase 3 in complexed with inhibitor
1q5k
homo-2-mer35-384
2×TMU;
Assess
Structure of a carvoxamide compound (15) (N-[4-(ISOQUINOLIN-7-YL)PYRIDIN-2-YL]CYCLOPROPANECARBOXAMI…
4pte
homo-2-mer36-385
2×2WF;
Assess
Identification of a Glycogen Synthase Kinase-3b Inhibitor that Attenuates Hyperactivity in CLOCK Mu…
3sd0
homo-2-mer35-384
2×TSK; 2×EPE;
Assess
Glycogen synthase kinase-3 beta in complex with 3-indolyl-4-arylmaleimide inhibitor
1r0e
homo-2-mer35-383
2×FLC; 2×DFN;
Assess
GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 6-BROMOINDIRUBIN-3'-OXIME
1uv5
homo-2-mer35-383
2×BRW; 4×PO4; 2×CL; 2×CO;
Assess
Glycogen synthase kinase-3 beta (GSK3) complex with a covalent [1,2,4]triazolo[1,5-a][1,3,5]triazin…
6h0u
homo-2-mer36-383
2×FKB; 1×MLI; 3×GOL; 2×CL; 1×NA;
Assess
STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 (GSK3B)
1i09
monomer25-384
2×PO4;
Assess
3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3
3l1s
monomer25-384
1×Z92;
Assess
Crystal structure of nonphosphorylated (Tyr216) GSK3b in complex with CX-4945
7z1g
monomer27-383
1×3NG; 5×MLI; 2×IMD;
Assess
Crystal structure of GSK3b in complex with CX-4945
7z1f
monomer28-383
1×3NG; 1×IMD; 2×YT3;
Assess
Crystal Structure of GSK3beta in complex with a Imidazopyridine inhibitor
4dit
monomer35-387
1×0KD;
Assess
6-Amino-4-(pyrimidin-4-yl)pyridones: Novel Glycogen Synthase Kinase-3 Inhibitors
3q3b
monomer35-386
1×55E;
Assess
Glycogen synthase kinase-3 beta in complex with bis-(indole)maleimide pyridinophane inhibitor
2ow3
monomer35-385
1×BIM;
Assess
Crystal structure of GSK-3b in complex with the 1H-indazole-3-carboxamide inhibitor 2
6y9r
monomer35-384
1×OH8; 1×ACT; 2×GOL;
Assess
Glycogen synthase kinase-3 beta (GSK3b) in complex with ligand 1
6tcu
monomer35-384
1×N1Q; 2×ACT;
Assess
Crystal structure of human glycogen synthase kinase 3 beta (GSK3b) in complex with inhibitor 142
3say
monomer35-384
1×OFT; 1×MLA; 1×FMT;
Assess
Crystal structure of GSK-3B in complex with pyrazine inhibitor C44
6hk3
monomer35-384
1×G8B; 1×MLI; 3×GOL; 1×CL; 1×DMS;
Assess
Crystal structure of human GSK3B in complex with G5
7u31
monomer36-385
1×CL; 1×L7I;
Assess
Glycogen Synthase Kinase 3 beta Complexed with BRD0209
5kpk
monomer35-384
1×6VK;
Assess
Crystal structure of GSK-3B in complex with pyrazine inhibitor C22
6hk4
monomer35-384
1×MLI; 3×GOL; 3×DMS; 1×G8E;
Assess
Crystal structure of human GSK3B in complex with ARN9133
7u33
monomer36-385
1×CL; 1×L7R;
Assess
Crystal structure of human GSK3B in complex with ARN1484
7u36
monomer36-385
1×CL; 1×L7W;
Assess
Crystal Structure of GSK3beta in complex with a benzoimidazol inhibitor
2o5k
monomer35-384
1×HBM;
Assess
Crystal structure of GSK-3b in complex with the imidazo[1,5-a]pyridine-3-carboxamide inhibitor 16
6y9s
monomer35-383
1×OHK; 2×ACT;
Assess
CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 3-[(CYCLOPROPYLMETHYL)AMINO] -N…
8dje
monomer36-384
1×U6S;
Assess
X-ray Co-Crystal Structure of Glycogen Synthase Kinase 3beta in Complex with an Inhibitor
3f7z
monomer35-383
1×34O;
Assess
GSK3beta inhibitor complex
3gb2
monomer35-383
1×G3B;
Assess
Glycogen Synthase Kinase 3 beta Complexed with BRD0705
5kpl
monomer36-384
1×6VL;
Assess
glycogen synthase Kinase 3beta inhibitor complex
3f88
monomer35-383
1×3HT; 1×2HT;
Assess
Crystal Structure of Glycogen Synthase Kinase-3 beta in Complex with BI-91BS
6gjo
monomer35-383
1×F1B;
Assess
Co-structure of human glycogen synthase kinase beta with 1-(6-((2-((6-amino-5-nitropyridin-2-yl)ami…
6v6l
monomer37-384
1×QQA; 1×PO4;
Assess
Crystal structure of GSK-3 beta in complex with NMS-869553A
3du8
monomer35-382
1×553;
Assess
CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 3-[(CYCLOPROPYLMETHYL)AMINO] -N…
8djd
monomer36-383
1×U3E;
Assess
Crystal structure of human GSK3B in complex with G12
7u2z
monomer35-382
1×L7C; 1×CL;
Assess
Crystal Structure of GSK3b in complex with inhibitor 1R
4j71
monomer36-383
1×1JX; 2×SO4; 1×CL;
Assess
CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH (4S)-N-{4-[(2S)-2-methylmorphol…
8djc
monomer35-382
1×UAU;
Assess
Crystal structure of GSK3b in complex with Compound 18: 2-[(cyclopropylcarbonyl)amino]-N-(4-phenylp…
5f95
monomer36-383
1×3UP;
Assess
Co-structure of human glycogen synthase kinase beta with a selective (5-imidazol-2-yl-4-phenylpyrim…
6b8j
monomer37-384
1×GOL; 1×65C;
Assess
Crystal Structure of Glycogen synthase kinase-3 beta (GSK3B) in Complex with PIK-75
6gn1
monomer36-383
1×CL; 1×F4N;
Assess
Glycogen Synthase Kinase 3 beta Complexed with BRD3731
5kpm
monomer36-383
1×6VM;
Assess
Crystal Structure of GSK3b in complex with inhibitor 15R
4j1r
monomer36-383
1×PO4; 1×I5R; 1×K;
Assess
Structure of Glycogen Synthase Kinase 3 beta (GSK3B) in complex with a ruthenium octasporine ligand…
3pup
monomer35-382
1×OS1;
Assess
GSK3-beta in complex with compound (S)-5c
7b6f
monomer36-382
1×SZW; 2×EDO; 2×SO4;
Assess
Crystal structure of GSK-3beta complexed with PF-04802367, a highly selective brain-penetrant kinas…
5k5n
monomer36-382
1×6QH; 1×SO4;
Assess
CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 2-[(4-CYANOPHENYL)AMINO]-N-(4-P…
8ff8
monomer36-382
1×XV0;
Assess
Structure of a carboxamine compound (26) (2-{2-[(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}-4-METHOXYP…
4ptg
monomer36-382
1×2WG;
Assess
X-RAY CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH BRD3937
5hlp
monomer36-382
1×65A;
Assess
Exploiting an Asp-Glu switch in Glycogen Synthase Kinase 3 to design paralog selective inhibitors f…
5t31
monomer35-381
1×6VL;
Assess
Crystal structure of GSK-3B in complex with pyrazine inhibitor C50
6hk7
monomer36-382
1×GOL; 1×DMS; 1×G8N;
Assess
Crystal structure of GSK3b in complex with Compound 15: 2-[(cyclopropylcarbonyl)amino]-N-(4-methoxy…
5f94
monomer36-381
1×3UO;
Assess
Gsk-3beta with inhibitor 6-chloro-N-cyclohexyl-4-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyridin-2-amine
4iq6
monomer37-382
1×IQ6;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1j1b.1.Bmonomer0.8823-386
1×ANP;100.00
Assess

1 SWISS-MODEL model built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 21j1b.1.Bmonomer0.8423-399
1×ANP;100.00
Assess